搜尋結果
Healthy Returns: 1 in 8 adults have taken Ozempic or other GLP-1s, survey says
CNBC· 19 小時前The use of a buzzy class of weight loss and diabetes medications is more common than ever. About 1 in 8 adults in the U.S ...
Hunter Biden Fails to Delay Trial for Gun Offenses in Delaware
Bloomberg· 19 小時前Hunter Biden will go on trial as planned in June for violations of federal gun laws, a judge ruled.
Judge rejects Hunter Biden's bid to delay his June trial on gun charges
CNBC· 20 小時前President Joe Biden's son is accused of lying about his drug use in October 2018 on a form ...
DEA's historic move to reschedule cannabis is no panacea
Reuters· 21 小時前, opens new tab of President Biden, has signaled its intent to move Cannabis from Schedule I to ...
Wegovy users keep weight off for four years, Novo Nordisk study says
Reuters· 21 小時前, opens new tab Wegovy obesity treatment maintained an average of 10% weight loss after four ...
Promoter group to sell stake worth $316 million in India's Cipla, CNBC-TV18 reports
Reuters· 22 小時前, opens new tab promoter group is looking to sell a 2.53% stake in India's third-largest ...
Jim Cramer says Home Depot’s earnings bolster the investment case for a different retail stock
CNBC· 22 小時前Home Depot : Shares fell nearly 1% after the home-improvement retailer's quarterly revenue ...
FDA Pledges to Ramp Up Fight Against Unauthorized Vapes
Bloomberg· 22 小時前The US Food and Drug Administration is stepping up its efforts to combat unauthorized tobacco ...
AI, biotech seen transforming healthcare
China Daily· 23 小時前New quality productive forces, represented by artificial intelligence and other digital technologies, are shaping China's ...
People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study says
CNBC· 23 小時前Patients taking Novo Nordisk's obesity drug Wegovy maintained an average of 10% weight loss ...